Sponsor:University of California, San FranciscoBrief Summary: This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT)…
Sponsor:ACADIA Pharmaceuticals Inc.Brief Summary: This is a pilot, hypothesis-generating study to explore the effects of pimavanserin and low-dose quetiapine in…
Sponsor:Sage TherapeuticsBrief Summary: The primary purpose of this study is to evaluate the safety and tolerability of SAGE-718 and its…
Sponsor:Brain Neurotherapy Bio, Inc.Brief Summary: The objective of this Phase 1b investigation is to evaluate the safety and potential clinical…
Sponsor:Michael J. Fox Foundation for Parkinson's ResearchBrief Summary: The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational,…
Sponsor:Cerevance Beta, Inc.Brief Summary: This is a phase 2 study, randomized, double-blind, placebo-controlled, multicenter study of oral CVN424 at two…
Sponsor:Enterin Inc.Brief Summary: This study will be conducted as an open-label safety follow-on to a multi-center, double-blind, randomized study. All…
Sponsor:Cerevel Therapeutics, LLCBrief Summary: The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics (PK) of…
Sponsor:University of California, Los AngelesBrief Summary: General anesthesia (GA) is a medically induced state of unresponsiveness and unconsciousness, which millions…
Sponsor:PrileniaBrief Summary: This is a multicenter, randomized, three-arm, parallel-group, double-blind, placebo-controlled, study to evaluate the efficacy, safety and pharmacokinetics (PK)…
